Oxford Cannabinoid Technologies Holdings PLC (LSE:OCTP, OTC:OCTHF), the biotech firm specialising in the development of prescription cannabinoid medicines, said the 128 million shares issued as part of its £640,000 subscription offer of stock will be admitted to trading on February 20.
The Markets by Proactive
Go to Proactive UK
Proactive’s coverage of London’s small caps continues on .com